REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/09/2025
Voltar para busca
Dado oficial do USPTO
CELLIGENICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CELLIGENICS
ST13
US500000079268611Classe
42, 44
Pedido
79268611
Registro
6144209
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
09/09/2025
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
17/06/2019
Data de registro
08/09/2020
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/09/2020
Última transação
09/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
SG
Examinador
MORRIS, KRISTINA
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Celligenics Pte. Ltd.
Representantes
David J. Byer K&L Gates LLP
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific and technological services and research and design relating theretoscientific research for product development in stem cell biologystem cells and their derivativesstem cell commercialization methodsancillary techniques and cell manufacturing services; industrial analysisquality and performance profiling of stem cells and their derivatives for standards developmentcomparison to standards and industrial research services in the field of cell and molecular biologystem cells and their derivativesresearch and analysis for standards development and quality control; stem cell research; stem cell research services; medical research services; biological research services; pharmaceutical research services; scientific research services; medical laboratory services; biochemistry research services; scientific research and industrial research services in the field of stem cell biology for clinicalcosmeceutical and biotech applications; pharmaceutical research and development services; scientific research for medical purposes; scientific laboratory services; provision of information relating to scientific research; provision of information relating to technological research in the field of stem cell biologystem cells and their derivativesmolecular and cell biologyimmunologycancer biology and methods of use of stem cells and their derivatives in clinicalcosmeceutical and biotech applications
Classe 44
Medical services; personal hygienic and beauty care for human beings; medical services relating to the removaltreatment and processing of stem cells; medical advisory services; medical analysis services for diagnostics and treatment purposes provided by medical laboratories; medical assistance services; medical care services; medical diagnostic services; medical information services; medical and healthcare services; medical testing for diagnostic or treatment purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/03/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/01/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
31/12/2020
FIMP
FINAL DISPOSITION PROCESSED
30/12/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/12/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/06/2020
PUBO
PUBLISHED FOR OPPOSITION
23/06/2020
GPNX
NOTIFICATION PROCESSED BY IB
19/06/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/06/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/06/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/05/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
19/05/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19/05/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
19/05/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
19/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/05/2020
RFNT
REFUSAL PROCESSED BY IB
22/11/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/11/2019
RFRR
REFUSAL PROCESSED BY MPU
01/11/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/10/2019
CNRT
NON-FINAL ACTION WRITTEN
11/10/2019
MAFR
APPLICATION FILING RECEIPT MAILED
08/10/2019
DOCK
ASSIGNED TO EXAMINER
04/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/10/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/10/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELLIGENICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.